Registered number
06929394
J K PHARMACY SOLUTIONS LTD
Filleted Accounts
30 June 2024
J K PHARMACY SOLUTIONS LTD
Registered number: 06929394
Balance Sheet
as at 30 June 2024
Notes 2024 2023
£ £
Fixed assets
Tangible assets 3 1,415 1,152
Current assets
Debtors 4 1,374 1,326
Cash at bank and in hand 5,131 8,722
6,505 10,048
Creditors: amounts falling due within one year 5 (2,653) (2,940)
Net current assets 3,852 7,108
Net assets 5,267 8,260
Capital and reserves
Called up share capital 2 2
Profit and loss account 5,265 8,258
Shareholder's funds 5,267 8,260
The director is satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The member has not required the company to obtain an audit in accordance with section 476 of the Act.
The director acknowledges her responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
KATHERINE PEETT
Director
Approved by the board on 16 January 2025
J K PHARMACY SOLUTIONS LTD
Notes to the Accounts
for the year ended 30 June 2024
1 Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Tangible fixed assets
Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows:
Plant and machinery 25% written down value
Taxation
A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
2 Employees 2024 2023
Number Number
Average number of persons employed by the company 1 1
3 Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 July 2023 4,130
Additions 735
At 30 June 2024 4,865
Depreciation
At 1 July 2023 2,978
Charge for the year 472
At 30 June 2024 3,450
Net book value
At 30 June 2024 1,415
At 30 June 2023 1,152
4 Debtors 2024 2023
£ £
Trade debtors 1,374 1,326
5 Creditors: amounts falling due within one year 2024 2023
£ £
Taxation and social security costs 1,582 1,737
Other creditors 1,071 1,203
2,653 2,940
6 Other information
J K PHARMACY SOLUTIONS LTD is a private company limited by shares and incorporated in England. Its registered office is:
2 WARBLER CLOSE
WATERLOOVILLE
HAMPSHIRE
PO8 9DU
J K PHARMACY SOLUTIONS LTD 06929394 false 2023-07-01 2024-06-30 2024-06-30 VT Final Accounts July 2024 KATHERINE PEETT No description of principal activity 06929394 2022-07-01 2023-06-30 06929394 core:WithinOneYear 2023-06-30 06929394 core:ShareCapital 2023-06-30 06929394 core:RetainedEarningsAccumulatedLosses 2023-06-30 06929394 2023-07-01 2024-06-30 06929394 bus:PrivateLimitedCompanyLtd 2023-07-01 2024-06-30 06929394 bus:AuditExemptWithAccountantsReport 2023-07-01 2024-06-30 06929394 bus:Director40 2023-07-01 2024-06-30 06929394 core:PlantMachinery 2023-07-01 2024-06-30 06929394 countries:England 2023-07-01 2024-06-30 06929394 bus:FRS102 2023-07-01 2024-06-30 06929394 bus:FilletedAccounts 2023-07-01 2024-06-30 06929394 2024-06-30 06929394 core:WithinOneYear 2024-06-30 06929394 core:ShareCapital 2024-06-30 06929394 core:RetainedEarningsAccumulatedLosses 2024-06-30 06929394 core:PlantMachinery 2024-06-30 06929394 2023-06-30 06929394 core:PlantMachinery 2023-06-30 iso4217:GBP xbrli:pure